Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

Note from PICI’s President and CEO Jeff Bluestone: Introducing Our New Brand

Since we launched in April 2016, we’ve been hard at work making measurable progress in cancer immunotherapy. As we evolve, our brand should evolve with us.

To explore our modern identity, we spoke with our scientific leaders. They described PICI as “breaking down barriers in science,” “a new paradigm in cancer research,” and “moving the field faster.”

These words became the heart of our new brand.

Yes, our brand reflects our bold mission and vision: to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases.

But it also allows us to truly highlight what makes PICI unique from any other organization in the field:

Our brand is now as ambitious as our research efforts.

-Jeff Bluestone, PhD